Page last updated: 2024-10-26

e 4031 and Heart Defects, Congenital

e 4031 has been researched along with Heart Defects, Congenital in 3 studies

E 4031: class III anti-arrhythmia agent; structure given in UD

Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, C1
Wang, K1
Zhang, H1
Danielsson, C1
Brask, J1
Sköld, AC1
Genead, R1
Andersson, A1
Andersson, U1
Stockling, K1
Pehrson, R1
Grinnemo, KH1
Salari, S1
Hellmold, H1
Danielsson, B1
Sylvén, C1
Elinder, F1
Franco, D1

Other Studies

3 other studies available for e 4031 and Heart Defects, Congenital

ArticleYear
Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
    Physiological measurement, 2017, Sep-21, Volume: 38, Issue:10

    Topics: Action Potentials; Arrhythmias, Cardiac; Disopyramide; Heart Conduction System; Heart Defects, Conge

2017
Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism.
    Cardiovascular research, 2013, Jan-01, Volume: 97, Issue:1

    Topics: Action Potentials; Animals; Atrioventricular Block; Cells, Cultured; Electrocardiography; ERG1 Potas

2013
Wiring the developing heart: a serious matter for adulthood.
    Cardiovascular research, 2013, Jan-01, Volume: 97, Issue:1

    Topics: Animals; Heart Defects, Congenital; Humans; Myocytes, Cardiac; Piperidines; Potassium Channel Blocke

2013